Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition • 09-14 May 2026
| 08:20 |
|
505-02-001.
Identifying network states linked to the therapeutic efficacy of deep brain stimulation for OCD
Impact: We found that therapeutic DBS in OCD reduced
recruitment of a default mode–like state and increased connectivity of a
salience–interoceptive state. Moving beyond trial-and-error DBS optimization,
these dynamic biomarkers can aid data-driven DBS optimization for
network-specific therapeutic engagement.
|
|
| 08:31 |
|
505-02-002.
Abnormal cortical topographic patterns associated with auditory verbal hallucination in first-episode schizophrenia
Impact: By linking functional
gradient disruptions to specific gene expression profiles and neurotransmitter
systems, Our work depicts the comprehensive landscape of topographic
abnormalities associated with AVH in schizophrenia, highlighting the role of
disrupted cortical hierarchy and network integration in its pathophysiology.
|
|
| 08:42 |
|
505-02-003.
Mapping intrinsic neural timescale alterations in major depressive disorder
Impact: Intrinsic neural timescales-based
analysis revealed temporal neural dynamics as a complementary
neurophysiological dimension for characterizing major depressive disorder. These findings provide
quantitative diagnostic biomarkers and mechanistic insights into elucidating
glutamatergic-GABAergic dysregulation, advancing precision psychiatry
frameworks.
|
|
| 08:53 |
|
505-02-004.
Shared and specific structural covariance network disruptions in adolescent and adult major depressive disorder
Impact: Our study identified
shared and age-specific alterations in structural covariance networks in
adolescent and adult MDD, revealing age-dependent connectivity and topological
patterns with distinct functional and clinical relevance, advancing
understanding of MDD neurodevelopment and informing age-tailored interventions.
|
|
| 09:04 |
|
505-02-005.
Longitudinal structural and functional remodeling of brain networks in treatment-resistant depression with SCC DBS
Impact: This study provides longitudinal MRI evidence that SCC-DBS induces rapid and coordinated structural and functional neuroplasticity in TRD. These findings identify early imaging biomarkers of therapeutic response and support the development of personalized, MRI-guided adaptive neuromodulation strategies for TRD.
|
|
| 09:15 |
|
505-02-006.
Altered functional connectivity and related behavioral–cognitive pattern in children with depressive genetic risk and symptom
Impact: This study revealed shared and distinct effects of
genetic risk and depressive symptoms on brain function of children. Sparse
canonical correlation analysis identified neural markers associated with risk
or symptoms, offering potential targets for early screening and psychological intervention.
|
|
| 09:26 |
|
505-02-007.
Aberrant Brain Network Topology in Youth with a High Risk for Bipolar disorder: A DTI Structural Connectome Study
Impact: These findings reveal early structural connectome alterations in youth at familial risk for BD, providing potential biomarkers for identifying individuals most vulnerable to illness onset and informing targeted preventive interventions to maintain cognitive-emotional regulation during adolescence.
|
|
| 09:37 |
|
505-02-008.
Constructing the Human Brain Metabolic Connectome with MR Spectroscopic Imaging
Impact: An
MRI-only metabolic connectome exposes a robust caudo-rostral gradient
and principal paths that are measurably disrupted in psychosis risk,
providing a fast, non-ionizing, multi-metabolite biomarker candidate
complementary to diffusion and BOLD-based connectomics.
|
|
| 09:48 |
|
505-02-009.
Directed Structural Connectivity Inferred from Network Diffusion in Humans and Non-Human Primates
Impact: White-matter
pathways have directionality that likely shapes disease progression, but
diffusion MRI cannot observe it. We introduce a physics-informed
structure–function model that estimates directed structural connectivity, showing recovery in simulation, concordance with macaque
tracers, and fair-to-excellent test–retest reliability in humans.
|
© 2026 International Society for Magnetic Resonance in Medicine